Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hoxb2
|
ENSMUSG00000075588.5 | homeobox B2 |
Dlx2
|
ENSMUSG00000023391.7 | distal-less homeobox 2 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_71612412_71612753 | Dlx2 | 65828 | 0.080269 | 0.92 | 1.2e-22 | Click! |
chr2_71625343_71625591 | Dlx2 | 78713 | 0.064943 | 0.88 | 7.2e-19 | Click! |
chr2_71625624_71625819 | Dlx2 | 78967 | 0.064665 | 0.86 | 3.7e-17 | Click! |
chr2_71546298_71546639 | Dlx2 | 286 | 0.874145 | 0.83 | 4.0e-15 | Click! |
chr2_71630055_71630257 | Dlx2 | 83402 | 0.059955 | 0.83 | 7.9e-15 | Click! |
chr11_96349606_96349757 | Hoxb2 | 844 | 0.334222 | -0.20 | 1.5e-01 | Click! |
chr11_96352663_96352814 | Hoxb2 | 1107 | 0.253350 | -0.15 | 2.6e-01 | Click! |
chr11_96351442_96351613 | Hoxb2 | 104 | 0.912927 | 0.14 | 2.9e-01 | Click! |
chr11_96351824_96352086 | Hoxb2 | 324 | 0.735016 | -0.10 | 4.6e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr3_139885937_139886924 | 63.62 |
Gm43678 |
predicted gene 43678 |
73666 |
0.11 |
chr17_11927079_11927230 | 57.95 |
Prkn |
parkin RBR E3 ubiquitin protein ligase |
81944 |
0.1 |
chr18_23036938_23037296 | 57.44 |
Nol4 |
nucleolar protein 4 |
1539 |
0.55 |
chr9_22826534_22827067 | 55.98 |
Gm27639 |
predicted gene, 27639 |
53965 |
0.15 |
chrX_169838405_169838582 | 55.97 |
Mid1 |
midline 1 |
10334 |
0.25 |
chr3_66102086_66102567 | 55.54 |
Gm36973 |
predicted gene, 36973 |
2521 |
0.19 |
chr4_87739581_87739778 | 54.44 |
Mllt3 |
myeloid/lymphoid or mixed-lineage leukemia; translocated to, 3 |
66615 |
0.13 |
chr13_99444397_99444879 | 53.93 |
Map1b |
microtubule-associated protein 1B |
171 |
0.95 |
chr15_40114597_40115428 | 52.44 |
9330182O14Rik |
RIKEN cDNA 9330182O14 gene |
19353 |
0.17 |
chr18_74956688_74957137 | 49.10 |
Lipg |
lipase, endothelial |
4350 |
0.11 |
chr13_83739197_83739995 | 48.59 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
733 |
0.33 |
chr13_73117014_73117369 | 47.84 |
Rpl31-ps2 |
ribosomal protein L31, pseudogene 2 |
116204 |
0.06 |
chr12_44839950_44840386 | 47.27 |
Gm15901 |
predicted gene 15901 |
83012 |
0.1 |
chr16_7448068_7448264 | 47.16 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
95196 |
0.1 |
chr8_58372581_58372772 | 47.11 |
Gm45635 |
predicted gene 45635 |
126089 |
0.06 |
chr3_40673604_40673797 | 46.46 |
Intu |
inturned planar cell polarity protein |
1079 |
0.49 |
chr2_72426764_72427187 | 46.34 |
Cdca7 |
cell division cycle associated 7 |
49184 |
0.13 |
chr2_168343654_168344081 | 45.84 |
Gm22704 |
predicted gene, 22704 |
8167 |
0.18 |
chr7_64884497_64884825 | 45.32 |
Nsmce3 |
NSE3 homolog, SMC5-SMC6 complex component |
11664 |
0.22 |
chr17_93377556_93377754 | 44.20 |
Gm50001 |
predicted gene, 50001 |
14043 |
0.22 |
chr15_4378780_4379184 | 43.95 |
Plcxd3 |
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
3478 |
0.36 |
chr12_51002047_51002408 | 43.62 |
Gm40421 |
predicted gene, 40421 |
2646 |
0.28 |
chr7_78887666_78887880 | 42.77 |
Mir7-2 |
microRNA 7-2 |
504 |
0.68 |
chr1_46830172_46830391 | 42.76 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5618 |
0.22 |
chr8_92545686_92545926 | 42.26 |
Gm45336 |
predicted gene 45336 |
80039 |
0.09 |
chr3_21357187_21357372 | 42.11 |
Gm29137 |
predicted gene 29137 |
88189 |
0.1 |
chr10_70458638_70458831 | 41.77 |
Fam13c |
family with sequence similarity 13, member C |
17808 |
0.19 |
chr4_24429638_24429836 | 41.37 |
Gm27243 |
predicted gene 27243 |
1153 |
0.54 |
chr4_85768203_85768551 | 40.90 |
Adamtsl1 |
ADAMTS-like 1 |
254050 |
0.02 |
chr3_78792451_78792970 | 40.90 |
Gm18952 |
predicted gene, 18952 |
34091 |
0.19 |
chr5_111195506_111196004 | 40.68 |
Gm43676 |
predicted gene 43676 |
1385 |
0.43 |
chr2_56257440_56257969 | 40.61 |
Gm13518 |
predicted gene 13518 |
217851 |
0.02 |
chr2_132427639_132427949 | 40.32 |
4921508D12Rik |
RIKEN cDNA 4921508D12 gene |
3053 |
0.25 |
chr2_165076987_165077575 | 39.68 |
1700025C18Rik |
RIKEN cDNA 1700025C18 gene |
13469 |
0.14 |
chr5_42067440_42068088 | 39.67 |
Gm16223 |
predicted gene 16223 |
196 |
0.97 |
chr16_77291582_77292053 | 39.35 |
Gm31258 |
predicted gene, 31258 |
13743 |
0.19 |
chrX_58445733_58445903 | 38.89 |
Gm14645 |
predicted gene 14645 |
17743 |
0.26 |
chr13_29370907_29371310 | 38.80 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
103499 |
0.08 |
chr1_167182388_167182722 | 38.77 |
Gm37994 |
predicted gene, 37994 |
3833 |
0.21 |
chr4_70811006_70811333 | 38.66 |
Gm11227 |
predicted gene 11227 |
261504 |
0.02 |
chr7_36476904_36477159 | 38.65 |
Gm25247 |
predicted gene, 25247 |
46420 |
0.17 |
chr12_26886181_26886584 | 38.50 |
4933409F18Rik |
RIKEN cDNA 4933409F18 gene |
51509 |
0.18 |
chr18_74907209_74907702 | 38.34 |
Gm24559 |
predicted gene, 24559 |
1021 |
0.37 |
chr4_117379821_117380196 | 37.96 |
Rnf220 |
ring finger protein 220 |
4551 |
0.2 |
chr19_59866689_59867059 | 37.90 |
Gm17203 |
predicted gene 17203 |
34188 |
0.18 |
chr15_74194149_74194481 | 37.70 |
Gm15387 |
predicted gene 15387 |
99982 |
0.07 |
chr6_54552680_54553127 | 37.69 |
Scrn1 |
secernin 1 |
1543 |
0.37 |
chr12_84532163_84533007 | 37.59 |
Lin52 |
lin-52 homolog (C. elegans) |
2541 |
0.25 |
chr13_52457883_52458068 | 37.52 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr14_22037549_22037700 | 37.48 |
Gm7480 |
predicted gene 7480 |
1521 |
0.34 |
chr7_72601928_72602360 | 37.36 |
Gm37620 |
predicted gene, 37620 |
155 |
0.96 |
chr5_9339805_9340127 | 37.22 |
Gm15733 |
predicted gene 15733 |
13793 |
0.19 |
chr2_141913595_141913820 | 37.13 |
Fau-ps1 |
Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed (fox derived), pseudogene 1 |
74918 |
0.13 |
chr10_67559869_67560062 | 37.12 |
4930563J15Rik |
RIKEN cDNA 4930563J15 gene |
10073 |
0.12 |
chr4_58670580_58670950 | 36.98 |
Gm12580 |
predicted gene 12580 |
12173 |
0.22 |
chr1_37097229_37097751 | 36.87 |
Vwa3b |
von Willebrand factor A domain containing 3B |
3041 |
0.26 |
chr3_47668909_47669138 | 36.71 |
Gm2229 |
predicted gene 2229 |
208685 |
0.03 |
chr3_3832009_3832194 | 36.67 |
Gm2071 |
predicted gene 2071 |
2817 |
0.34 |
chr7_111896291_111896806 | 36.66 |
Gm45588 |
predicted gene 45588 |
37993 |
0.17 |
chr6_107711195_107711474 | 36.46 |
4933431M02Rik |
RIKEN cDNA 4933431M02 gene |
83560 |
0.1 |
chr15_88468083_88468426 | 36.46 |
Zdhhc25 |
zinc finger, DHHC domain containing 25 |
132048 |
0.05 |
chr13_19668619_19668818 | 36.30 |
Gm47606 |
predicted gene, 47606 |
5216 |
0.18 |
chr2_63669718_63669895 | 36.27 |
Gm23503 |
predicted gene, 23503 |
237612 |
0.02 |
chr2_47834160_47834335 | 36.03 |
Gm25959 |
predicted gene, 25959 |
292263 |
0.01 |
chr7_63669022_63669353 | 36.00 |
Otud7a |
OTU domain containing 7A |
18372 |
0.2 |
chr5_5134656_5134845 | 35.96 |
Gm43623 |
predicted gene 43623 |
5357 |
0.21 |
chr13_83750227_83750397 | 35.77 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
11449 |
0.12 |
chr17_49816718_49817010 | 35.76 |
Gm16555 |
predicted gene 16555 |
4961 |
0.27 |
chr6_17797574_17797931 | 35.62 |
Gm26738 |
predicted gene, 26738 |
37433 |
0.13 |
chr8_100516007_100516194 | 35.56 |
Gm45296 |
predicted gene 45296 |
77342 |
0.12 |
chr14_79880159_79880358 | 35.50 |
Gm6999 |
predicted gene 6999 |
10739 |
0.16 |
chr4_98578155_98578507 | 35.46 |
Gm22625 |
predicted gene, 22625 |
20466 |
0.18 |
chr13_78324889_78325040 | 35.46 |
Gm3963 |
predicted gene 3963 |
37880 |
0.11 |
chr3_35324266_35324460 | 35.29 |
Gm25442 |
predicted gene, 25442 |
1251 |
0.55 |
chr4_13480505_13480805 | 35.26 |
Gm11826 |
predicted gene 11826 |
2537 |
0.36 |
chr6_127701185_127701975 | 35.24 |
Gm43634 |
predicted gene 43634 |
57140 |
0.08 |
chr12_78987630_78988054 | 35.13 |
Tmem229b |
transmembrane protein 229B |
4364 |
0.21 |
chr6_137699415_137699798 | 35.08 |
Strap |
serine/threonine kinase receptor associated protein |
35472 |
0.16 |
chr17_66869624_66870037 | 35.02 |
Gm49940 |
predicted gene, 49940 |
7590 |
0.18 |
chr18_15544080_15544457 | 34.98 |
Aqp4 |
aquaporin 4 |
133286 |
0.05 |
chr12_48820304_48820469 | 34.98 |
AC124542.1 |
olfactory receptor 1400, pseudogene 1 |
85658 |
0.1 |
chr8_89135140_89135331 | 34.93 |
Gm6625 |
predicted gene 6625 |
11823 |
0.24 |
chr5_78622542_78622942 | 34.88 |
Gm43232 |
predicted gene 43232 |
82214 |
0.11 |
chr12_68217227_68217378 | 34.87 |
Gm47454 |
predicted gene, 47454 |
115320 |
0.06 |
chr11_26806852_26807151 | 34.84 |
Gm12070 |
predicted gene 12070 |
20368 |
0.19 |
chr6_138754677_138754895 | 34.81 |
Igbp1b |
immunoglobulin (CD79A) binding protein 1b |
96242 |
0.08 |
chr5_116895407_116895611 | 34.70 |
Gm43122 |
predicted gene 43122 |
64955 |
0.1 |
chr14_12338097_12338549 | 34.66 |
Gm24578 |
predicted gene, 24578 |
4419 |
0.14 |
chr6_40024235_40024578 | 34.51 |
Gm37995 |
predicted gene, 37995 |
2488 |
0.33 |
chr15_59973915_59974066 | 34.51 |
Gm7083 |
predicted gene 7083 |
3732 |
0.23 |
chr1_6752243_6752413 | 34.41 |
St18 |
suppression of tumorigenicity 18 |
14753 |
0.25 |
chr13_29565628_29566161 | 34.23 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
48440 |
0.19 |
chr17_16089277_16089512 | 34.21 |
Gm49778 |
predicted gene, 49778 |
73757 |
0.1 |
chr11_25696299_25696505 | 34.06 |
Gm23514 |
predicted gene, 23514 |
11262 |
0.27 |
chr4_126648482_126648847 | 34.02 |
Gm12933 |
predicted gene 12933 |
16590 |
0.13 |
chr4_24429061_24429567 | 34.01 |
Gm27243 |
predicted gene 27243 |
1576 |
0.43 |
chr2_82847422_82847589 | 33.78 |
Fsip2 |
fibrous sheath-interacting protein 2 |
96129 |
0.09 |
chr11_93488029_93488206 | 33.60 |
Gm24856 |
predicted gene, 24856 |
74793 |
0.12 |
chr10_29143863_29144732 | 33.57 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr15_18818116_18818289 | 33.56 |
C030047K22Rik |
RIKEN cDNA C030047K22 gene |
572 |
0.56 |
chr4_28143160_28143344 | 33.52 |
Gm11911 |
predicted gene 11911 |
76075 |
0.11 |
chr7_79501638_79502069 | 33.51 |
Mir9-3hg |
Mir9-3 host gene |
1732 |
0.18 |
chr10_3920376_3921003 | 33.44 |
Gm23023 |
predicted gene, 23023 |
14188 |
0.15 |
chr1_46829988_46830169 | 33.33 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5821 |
0.22 |
chr8_61515184_61515647 | 33.30 |
Palld |
palladin, cytoskeletal associated protein |
485 |
0.84 |
chr4_39344820_39345025 | 33.28 |
Gm23607 |
predicted gene, 23607 |
49459 |
0.14 |
chr10_15249538_15249689 | 33.24 |
Gm18188 |
predicted gene, 18188 |
21565 |
0.23 |
chr2_28780313_28780498 | 33.24 |
Gm13385 |
predicted gene 13385 |
13164 |
0.13 |
chr18_17383276_17383802 | 33.23 |
4921533I20Rik |
Riken cDNA 4921533I20 gene |
63809 |
0.15 |
chr1_52470778_52471095 | 33.20 |
Nab1 |
Ngfi-A binding protein 1 |
3879 |
0.19 |
chr12_4523765_4524306 | 33.14 |
Gm31938 |
predicted gene, 31938 |
78 |
0.96 |
chr8_12126295_12126640 | 32.92 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
152352 |
0.03 |
chr17_88764144_88764434 | 32.87 |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
9767 |
0.24 |
chr5_78622272_78622464 | 32.86 |
Gm43232 |
predicted gene 43232 |
81840 |
0.11 |
chr13_101203160_101203326 | 32.85 |
5930438M14Rik |
RIKEN cDNA 5930438M14 gene |
28884 |
0.19 |
chr13_116087410_116087561 | 32.80 |
Gm47893 |
predicted gene, 47893 |
8550 |
0.28 |
chr3_27059899_27060315 | 32.78 |
Gm7558 |
predicted gene 7558 |
12154 |
0.17 |
chr15_95217343_95217494 | 32.77 |
1700129L04Rik |
RIKEN cDNA 1700129L04 gene |
55024 |
0.17 |
chr3_34561729_34562051 | 32.67 |
Sox2ot |
SOX2 overlapping transcript (non-protein coding) |
1498 |
0.34 |
chr14_103587274_103587565 | 32.67 |
Slain1 |
SLAIN motif family, member 1 |
62809 |
0.1 |
chr4_55929179_55929426 | 32.61 |
Gm12519 |
predicted gene 12519 |
64437 |
0.14 |
chr13_36518354_36518571 | 32.59 |
Fars2 |
phenylalanine-tRNA synthetase 2 (mitochondrial) |
18635 |
0.16 |
chr14_68355462_68355920 | 32.54 |
Gm31227 |
predicted gene, 31227 |
105940 |
0.06 |
chr6_91324837_91325054 | 32.44 |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
40126 |
0.12 |
chr18_50397132_50397306 | 32.41 |
Fam170a |
family with sequence similarity 170, member A |
118848 |
0.06 |
chr16_67610911_67611282 | 32.29 |
Cadm2 |
cell adhesion molecule 2 |
9397 |
0.25 |
chr14_35112923_35113111 | 32.23 |
Gm49034 |
predicted gene, 49034 |
106421 |
0.07 |
chr11_43270024_43270232 | 32.17 |
Gm12146 |
predicted gene 12146 |
10344 |
0.19 |
chr18_81831298_81831489 | 32.16 |
Gm30454 |
predicted gene, 30454 |
18623 |
0.19 |
chr19_41164805_41164972 | 32.14 |
Tll2 |
tolloid-like 2 |
41886 |
0.16 |
chr13_40606764_40607229 | 32.02 |
Gm47039 |
predicted gene, 47039 |
517 |
0.78 |
chr5_150894457_150894771 | 31.96 |
Gm43298 |
predicted gene 43298 |
11972 |
0.2 |
chr10_31551495_31551682 | 31.86 |
Gm47693 |
predicted gene, 47693 |
5852 |
0.19 |
chr17_63807674_63808197 | 31.84 |
Fer |
fer (fms/fps related) protein kinase |
55127 |
0.13 |
chr3_57919632_57919807 | 31.83 |
Gm24531 |
predicted gene, 24531 |
2468 |
0.24 |
chr3_34504632_34504783 | 31.77 |
Gm29135 |
predicted gene 29135 |
22500 |
0.16 |
chr7_142902999_142903346 | 31.76 |
Th |
tyrosine hydroxylase |
3158 |
0.22 |
chr4_54331384_54331565 | 31.68 |
Gm12469 |
predicted gene 12469 |
95598 |
0.08 |
chr6_12337029_12337231 | 31.66 |
Thsd7a |
thrombospondin, type I, domain containing 7A |
12437 |
0.3 |
chr12_25871193_25871842 | 31.59 |
Gm47733 |
predicted gene, 47733 |
364 |
0.91 |
chr19_56476541_56476761 | 31.56 |
Plekhs1 |
pleckstrin homology domain containing, family S member 1 |
2250 |
0.3 |
chr3_6183428_6183711 | 31.56 |
Gm6162 |
predicted gene 6162 |
15745 |
0.23 |
chr4_18046647_18046997 | 31.45 |
Mmp16 |
matrix metallopeptidase 16 |
4935 |
0.29 |
chr3_5347364_5347521 | 31.45 |
Zfhx4 |
zinc finger homeodomain 4 |
105770 |
0.07 |
chr13_84056571_84056869 | 31.42 |
Gm17750 |
predicted gene, 17750 |
8052 |
0.22 |
chr14_64233778_64233929 | 31.36 |
9630015K15Rik |
RIKEN cDNA 9630015K15 gene |
117539 |
0.05 |
chr12_29789878_29790063 | 31.35 |
Myt1l |
myelin transcription factor 1-like |
50240 |
0.17 |
chr2_50971381_50971555 | 31.29 |
Gm13498 |
predicted gene 13498 |
61784 |
0.14 |
chr18_46997978_46998292 | 31.26 |
Gm22791 |
predicted gene, 22791 |
12654 |
0.15 |
chr6_61042953_61043250 | 31.15 |
Gm43892 |
predicted gene, 43892 |
1892 |
0.33 |
chr2_106512677_106513062 | 31.07 |
Gm14015 |
predicted gene 14015 |
10234 |
0.26 |
chr4_148291962_148292123 | 31.03 |
Disp3 |
dispatched RND transporter family member 3 |
4077 |
0.19 |
chr6_61066614_61066949 | 31.02 |
Gm43893 |
predicted gene, 43893 |
2474 |
0.28 |
chr8_13454338_13454755 | 31.00 |
Tmem255b |
transmembrane protein 255B |
932 |
0.51 |
chr2_22620080_22620281 | 30.97 |
Gad2 |
glutamic acid decarboxylase 2 |
2025 |
0.23 |
chr17_62659448_62659775 | 30.91 |
Gm25800 |
predicted gene, 25800 |
202491 |
0.03 |
chr13_119753907_119754230 | 30.81 |
Nim1k |
NIM1 serine/threonine protein kinase |
1814 |
0.21 |
chr17_90704847_90705136 | 30.81 |
Nrxn1 |
neurexin I |
4217 |
0.32 |
chr17_69686012_69686193 | 30.78 |
Gm49895 |
predicted gene, 49895 |
89910 |
0.08 |
chr1_138497460_138497658 | 30.78 |
Gm28501 |
predicted gene 28501 |
18056 |
0.2 |
chr18_8044886_8045210 | 30.75 |
Gm4833 |
predicted gene 4833 |
6155 |
0.28 |
chr12_102511368_102511747 | 30.73 |
Golga5 |
golgi autoantigen, golgin subfamily a, 5 |
27100 |
0.14 |
chr14_123065129_123065306 | 30.72 |
AA536875 |
expressed sequence AA536875 |
21935 |
0.22 |
chr12_65428316_65428602 | 30.71 |
Gm26015 |
predicted gene, 26015 |
22489 |
0.22 |
chr4_82915979_82916332 | 30.62 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
1721 |
0.41 |
chr3_35332947_35333329 | 30.62 |
Gm25442 |
predicted gene, 25442 |
7524 |
0.26 |
chr11_112501711_112502406 | 30.61 |
BC006965 |
cDNA sequence BC006965 |
167340 |
0.04 |
chr8_36014873_36015024 | 30.58 |
Rps12-ps24 |
ribosomal protein S12, pseudogene 24 |
10805 |
0.2 |
chr10_16052455_16052829 | 30.57 |
C330004P14Rik |
RIKEN cDNA C330004P14 gene |
260865 |
0.02 |
chr13_29371351_29371690 | 30.57 |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
103087 |
0.08 |
chr19_15668305_15668530 | 30.57 |
Gm24319 |
predicted gene, 24319 |
11587 |
0.3 |
chr7_96865260_96865776 | 30.51 |
Gm25712 |
predicted gene, 25712 |
2139 |
0.28 |
chr2_49719443_49719668 | 30.51 |
Kif5c |
kinesin family member 5C |
3012 |
0.3 |
chr3_110010549_110010756 | 30.50 |
Gm12535 |
predicted gene 12535 |
103268 |
0.07 |
chr13_8202686_8203175 | 30.43 |
Adarb2 |
adenosine deaminase, RNA-specific, B2 |
8 |
0.97 |
chr16_43603831_43604250 | 30.41 |
Mir568 |
microRNA 568 |
36615 |
0.15 |
chr13_13820325_13820514 | 30.36 |
Gng4 |
guanine nucleotide binding protein (G protein), gamma 4 |
1140 |
0.45 |
chr3_88205312_88205479 | 30.35 |
AI849053 |
expressed sequence AI849053 |
800 |
0.34 |
chr3_98990771_98991097 | 30.34 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
49678 |
0.1 |
chr18_21185734_21186067 | 30.25 |
Gm6378 |
predicted pseudogene 6378 |
108791 |
0.05 |
chr17_73477274_73477427 | 30.18 |
Gm49876 |
predicted gene, 49876 |
16901 |
0.16 |
chr8_40650752_40651179 | 30.10 |
Mtmr7 |
myotubularin related protein 7 |
16168 |
0.14 |
chr1_165935347_165935547 | 30.08 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
436 |
0.79 |
chr9_37625246_37625717 | 30.07 |
Siae |
sialic acid acetylesterase |
3827 |
0.14 |
chr7_125036708_125036896 | 30.07 |
Gm45093 |
predicted gene 45093 |
32689 |
0.19 |
chr13_78581171_78581365 | 30.06 |
Gm48402 |
predicted gene, 48402 |
56749 |
0.14 |
chr8_26677560_26678005 | 30.05 |
Gm32098 |
predicted gene, 32098 |
9476 |
0.18 |
chrX_166344291_166344543 | 30.05 |
Gpm6b |
glycoprotein m6b |
275 |
0.93 |
chr13_25751437_25751638 | 30.04 |
Gm11350 |
predicted gene 11350 |
70394 |
0.13 |
chr1_68142571_68142936 | 30.04 |
Gm37100 |
predicted gene, 37100 |
26206 |
0.23 |
chr4_22066929_22067080 | 30.02 |
Gm11880 |
predicted gene 11880 |
50528 |
0.14 |
chr8_12127510_12127825 | 30.00 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
151152 |
0.03 |
chr16_63806441_63806811 | 29.92 |
Epha3 |
Eph receptor A3 |
56787 |
0.15 |
chr1_135645775_135646042 | 29.92 |
Nav1 |
neuron navigator 1 |
42197 |
0.12 |
chr11_80623114_80623380 | 29.91 |
C030013C21Rik |
RIKEN cDNA C030013C21 gene |
114141 |
0.05 |
chr11_71414747_71415135 | 29.85 |
Gm16013 |
predicted gene 16013 |
21239 |
0.21 |
chr12_44479679_44479987 | 29.79 |
Nrcam |
neuronal cell adhesion molecule |
23173 |
0.22 |
chr16_91140532_91140860 | 29.74 |
Gm49612 |
predicted gene, 49612 |
5220 |
0.12 |
chr10_17479308_17479459 | 29.68 |
Gm47768 |
predicted gene, 47768 |
35347 |
0.16 |
chr16_59854456_59854822 | 29.68 |
Epha6 |
Eph receptor A6 |
151082 |
0.04 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
42.9 | 128.6 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
16.8 | 50.3 | GO:0060166 | olfactory pit development(GO:0060166) |
13.8 | 55.3 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
12.9 | 90.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
12.1 | 36.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
11.0 | 88.4 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
11.0 | 54.8 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
10.6 | 42.3 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
9.6 | 38.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
9.6 | 28.9 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
9.3 | 9.3 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
9.3 | 27.8 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
9.2 | 27.7 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) |
9.1 | 36.2 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
9.0 | 26.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
8.9 | 80.1 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
8.6 | 34.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
8.5 | 25.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
8.1 | 72.8 | GO:0060013 | righting reflex(GO:0060013) |
8.1 | 24.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
7.8 | 23.5 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
7.7 | 85.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
7.3 | 21.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
7.0 | 14.1 | GO:1903802 | L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
7.0 | 27.9 | GO:0007258 | JUN phosphorylation(GO:0007258) |
6.9 | 13.9 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
6.9 | 48.3 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
6.8 | 20.4 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
6.8 | 74.6 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
6.8 | 27.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
6.8 | 33.8 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
6.7 | 26.8 | GO:0060594 | mammary gland specification(GO:0060594) |
6.7 | 20.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
6.6 | 19.9 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
6.6 | 26.4 | GO:0030910 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
6.3 | 12.6 | GO:0046959 | habituation(GO:0046959) |
6.3 | 25.2 | GO:0060486 | Clara cell differentiation(GO:0060486) |
6.2 | 43.3 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
6.1 | 18.4 | GO:0007412 | axon target recognition(GO:0007412) |
6.1 | 49.0 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
6.1 | 30.6 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
6.1 | 12.2 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
6.0 | 17.9 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
5.9 | 23.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
5.8 | 35.0 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
5.8 | 17.4 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
5.8 | 11.6 | GO:0021564 | vagus nerve development(GO:0021564) |
5.8 | 11.6 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
5.7 | 17.2 | GO:0030070 | insulin processing(GO:0030070) |
5.6 | 11.3 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
5.6 | 22.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
5.5 | 33.3 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
5.5 | 11.1 | GO:0048880 | sensory system development(GO:0048880) |
5.5 | 16.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
5.5 | 5.5 | GO:0060174 | limb bud formation(GO:0060174) |
5.5 | 11.0 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
5.3 | 26.3 | GO:0019532 | oxalate transport(GO:0019532) |
5.2 | 15.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
5.1 | 50.8 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
5.1 | 20.3 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
5.1 | 15.2 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
5.0 | 5.0 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
5.0 | 20.2 | GO:0023041 | neuronal signal transduction(GO:0023041) |
5.0 | 24.8 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
4.9 | 19.8 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
4.8 | 14.4 | GO:0001927 | exocyst assembly(GO:0001927) |
4.7 | 19.0 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
4.7 | 18.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
4.7 | 14.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
4.7 | 23.3 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
4.7 | 18.6 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
4.6 | 18.3 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
4.6 | 41.0 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
4.6 | 77.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
4.5 | 4.5 | GO:0031223 | auditory behavior(GO:0031223) |
4.5 | 18.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
4.5 | 9.0 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
4.5 | 22.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
4.5 | 31.5 | GO:0021871 | forebrain regionalization(GO:0021871) |
4.5 | 13.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
4.5 | 13.4 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
4.5 | 17.8 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
4.4 | 8.9 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
4.4 | 8.8 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
4.4 | 8.8 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
4.4 | 13.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
4.3 | 4.3 | GO:0014028 | notochord formation(GO:0014028) |
4.3 | 17.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
4.2 | 12.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
4.1 | 28.7 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
4.1 | 12.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
4.0 | 8.1 | GO:0051944 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
4.0 | 12.1 | GO:0072092 | ureteric bud invasion(GO:0072092) |
4.0 | 16.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
4.0 | 12.0 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
4.0 | 11.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
3.9 | 11.7 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) |
3.9 | 15.5 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
3.8 | 7.6 | GO:0061642 | chemoattraction of axon(GO:0061642) |
3.8 | 30.1 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
3.8 | 11.3 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
3.7 | 11.2 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
3.7 | 3.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
3.7 | 36.9 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
3.6 | 7.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
3.6 | 3.6 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
3.6 | 25.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
3.6 | 17.9 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
3.6 | 14.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
3.6 | 10.7 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
3.5 | 42.2 | GO:0048268 | clathrin coat assembly(GO:0048268) |
3.5 | 14.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
3.4 | 13.7 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
3.4 | 6.8 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
3.3 | 13.3 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
3.3 | 3.3 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
3.3 | 13.2 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
3.3 | 6.6 | GO:0043366 | beta selection(GO:0043366) |
3.3 | 3.3 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
3.3 | 9.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
3.3 | 13.0 | GO:0090427 | activation of meiosis(GO:0090427) |
3.3 | 3.3 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
3.2 | 12.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
3.2 | 6.4 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
3.2 | 6.4 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
3.2 | 9.6 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
3.2 | 12.8 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
3.2 | 16.0 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
3.2 | 9.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
3.1 | 25.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
3.1 | 12.4 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
3.1 | 6.2 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
3.1 | 12.4 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
3.1 | 24.7 | GO:0097120 | receptor localization to synapse(GO:0097120) |
3.1 | 6.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
3.1 | 9.2 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
3.0 | 12.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
3.0 | 14.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.9 | 231.8 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
2.9 | 2.9 | GO:0021861 | forebrain radial glial cell differentiation(GO:0021861) |
2.9 | 8.8 | GO:0052203 | modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
2.9 | 5.8 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
2.9 | 14.5 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
2.9 | 14.4 | GO:0048664 | neuron fate determination(GO:0048664) |
2.9 | 8.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
2.8 | 150.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
2.8 | 14.2 | GO:0071625 | vocalization behavior(GO:0071625) |
2.8 | 39.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
2.8 | 11.3 | GO:0035627 | ceramide transport(GO:0035627) |
2.8 | 62.3 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.8 | 8.4 | GO:0060005 | vestibular reflex(GO:0060005) |
2.8 | 8.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.8 | 11.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
2.8 | 13.9 | GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
2.8 | 5.5 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
2.8 | 8.3 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
2.7 | 2.7 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
2.7 | 8.0 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
2.7 | 10.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
2.6 | 13.2 | GO:0032962 | positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
2.6 | 5.2 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
2.5 | 7.6 | GO:0060437 | lung growth(GO:0060437) |
2.5 | 5.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
2.5 | 15.2 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
2.5 | 2.5 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
2.5 | 5.0 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
2.5 | 7.5 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
2.5 | 17.4 | GO:0060179 | male mating behavior(GO:0060179) |
2.5 | 10.0 | GO:0060676 | ureteric bud formation(GO:0060676) |
2.5 | 7.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
2.5 | 29.8 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
2.5 | 14.8 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
2.4 | 7.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
2.4 | 21.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
2.4 | 2.4 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
2.4 | 7.1 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
2.3 | 13.9 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
2.3 | 18.4 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
2.3 | 6.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
2.3 | 6.9 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
2.3 | 11.3 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.3 | 2.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
2.3 | 6.8 | GO:0030035 | microspike assembly(GO:0030035) |
2.2 | 11.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.2 | 2.2 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
2.2 | 11.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
2.2 | 2.2 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
2.2 | 4.4 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
2.2 | 10.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
2.1 | 32.0 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
2.1 | 2.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
2.1 | 8.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
2.1 | 12.7 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
2.1 | 6.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
2.1 | 6.2 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
2.1 | 14.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.1 | 32.8 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
2.0 | 4.1 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
2.0 | 16.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
2.0 | 4.0 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
2.0 | 18.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
2.0 | 8.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
2.0 | 7.9 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.0 | 2.0 | GO:0042713 | sperm ejaculation(GO:0042713) |
2.0 | 4.0 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
2.0 | 2.0 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
1.9 | 1.9 | GO:0006848 | pyruvate transport(GO:0006848) |
1.9 | 5.7 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.9 | 3.8 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
1.9 | 1.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
1.9 | 9.5 | GO:0090244 | Wnt signaling pathway involved in somitogenesis(GO:0090244) |
1.9 | 7.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
1.9 | 1.9 | GO:0098828 | modulation of inhibitory postsynaptic potential(GO:0098828) |
1.9 | 3.8 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
1.9 | 7.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.9 | 7.5 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
1.9 | 1.9 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
1.9 | 7.4 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
1.8 | 12.8 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
1.8 | 1.8 | GO:0061590 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
1.8 | 5.5 | GO:0021544 | subpallium development(GO:0021544) |
1.8 | 10.9 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
1.8 | 3.6 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
1.8 | 7.2 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.8 | 3.6 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.8 | 1.8 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
1.8 | 21.4 | GO:0016486 | peptide hormone processing(GO:0016486) |
1.7 | 8.7 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
1.7 | 10.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
1.7 | 5.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.7 | 18.8 | GO:0001553 | luteinization(GO:0001553) |
1.7 | 1.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.7 | 6.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
1.7 | 3.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
1.7 | 3.4 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.7 | 20.1 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
1.7 | 6.7 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
1.7 | 6.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
1.7 | 1.7 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.6 | 3.3 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
1.6 | 3.3 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
1.6 | 6.5 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
1.6 | 3.3 | GO:0070253 | somatostatin secretion(GO:0070253) |
1.6 | 4.8 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
1.6 | 4.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.6 | 1.6 | GO:2001280 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
1.6 | 11.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
1.6 | 4.7 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
1.6 | 20.3 | GO:0001964 | startle response(GO:0001964) |
1.6 | 4.7 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
1.5 | 4.6 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.5 | 4.6 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.5 | 1.5 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
1.5 | 3.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
1.5 | 42.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.5 | 4.5 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.5 | 1.5 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
1.5 | 1.5 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
1.5 | 13.3 | GO:0071435 | potassium ion export(GO:0071435) |
1.5 | 5.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.5 | 5.9 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
1.5 | 8.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
1.4 | 2.9 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
1.4 | 4.3 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
1.4 | 4.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
1.4 | 2.8 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.4 | 1.4 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
1.4 | 4.2 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
1.4 | 4.2 | GO:0002930 | trabecular meshwork development(GO:0002930) |
1.4 | 4.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
1.4 | 2.8 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
1.4 | 5.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.4 | 4.2 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
1.4 | 5.5 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.4 | 5.5 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
1.4 | 5.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.4 | 8.2 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
1.3 | 5.4 | GO:0034239 | regulation of macrophage fusion(GO:0034239) |
1.3 | 5.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
1.3 | 4.0 | GO:0006203 | dGTP catabolic process(GO:0006203) |
1.3 | 1.3 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
1.3 | 4.0 | GO:0048840 | otolith development(GO:0048840) |
1.3 | 6.6 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.3 | 4.0 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
1.3 | 1.3 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
1.3 | 1.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.3 | 7.9 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.3 | 3.9 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
1.3 | 1.3 | GO:1903935 | negative regulation of cardiac muscle contraction(GO:0055118) response to sodium arsenite(GO:1903935) |
1.3 | 6.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.3 | 2.6 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.3 | 5.2 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
1.3 | 6.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
1.3 | 2.6 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
1.3 | 5.1 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
1.3 | 3.8 | GO:0030432 | peristalsis(GO:0030432) |
1.2 | 6.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
1.2 | 6.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
1.2 | 1.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.2 | 3.7 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
1.2 | 3.7 | GO:0006046 | N-acetylglucosamine catabolic process(GO:0006046) |
1.2 | 2.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
1.2 | 1.2 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
1.2 | 3.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
1.2 | 9.6 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
1.2 | 6.0 | GO:0015808 | L-alanine transport(GO:0015808) |
1.2 | 2.4 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
1.2 | 2.4 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
1.2 | 2.4 | GO:0051665 | membrane raft localization(GO:0051665) |
1.2 | 1.2 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
1.2 | 1.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
1.2 | 3.5 | GO:0051590 | positive regulation of neurotransmitter transport(GO:0051590) |
1.1 | 3.4 | GO:0007525 | somatic muscle development(GO:0007525) |
1.1 | 6.7 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.1 | 3.4 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
1.1 | 7.8 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
1.1 | 2.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
1.1 | 1.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) |
1.1 | 5.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
1.1 | 3.3 | GO:0022038 | corpus callosum development(GO:0022038) |
1.1 | 3.3 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.1 | 2.2 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) |
1.1 | 3.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
1.1 | 17.2 | GO:0007616 | long-term memory(GO:0007616) |
1.1 | 7.5 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
1.1 | 9.7 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
1.1 | 3.2 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
1.1 | 1.1 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
1.1 | 2.1 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
1.1 | 2.1 | GO:0008355 | olfactory learning(GO:0008355) |
1.1 | 3.2 | GO:0030242 | pexophagy(GO:0030242) |
1.0 | 8.3 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
1.0 | 5.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
1.0 | 5.2 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
1.0 | 1.0 | GO:0021554 | optic nerve development(GO:0021554) |
1.0 | 25.6 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
1.0 | 3.1 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
1.0 | 1.0 | GO:1904339 | negative regulation of dopaminergic neuron differentiation(GO:1904339) |
1.0 | 2.0 | GO:0090148 | membrane fission(GO:0090148) |
1.0 | 13.1 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
1.0 | 12.1 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
1.0 | 2.0 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.0 | 3.0 | GO:0031296 | B cell costimulation(GO:0031296) |
1.0 | 3.0 | GO:0071316 | cellular response to nicotine(GO:0071316) |
1.0 | 3.0 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.0 | 9.0 | GO:1990403 | embryonic brain development(GO:1990403) |
1.0 | 3.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
1.0 | 3.0 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
1.0 | 5.0 | GO:0050957 | equilibrioception(GO:0050957) |
1.0 | 4.9 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
1.0 | 8.9 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.0 | 2.9 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.0 | 4.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
1.0 | 1.0 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
1.0 | 2.9 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
1.0 | 6.8 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.0 | 1.9 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.9 | 2.8 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.9 | 5.7 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.9 | 3.7 | GO:0060307 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.9 | 3.7 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.9 | 0.9 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.9 | 13.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.9 | 3.6 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.9 | 5.4 | GO:0006108 | malate metabolic process(GO:0006108) |
0.9 | 1.8 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.9 | 1.8 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
0.9 | 2.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.9 | 5.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.9 | 2.7 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.9 | 0.9 | GO:0035106 | operant conditioning(GO:0035106) |
0.9 | 1.8 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.9 | 3.5 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.9 | 4.4 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.9 | 2.6 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.9 | 0.9 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.9 | 1.7 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.9 | 7.7 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.9 | 3.4 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.8 | 1.7 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.8 | 0.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.8 | 2.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.8 | 0.8 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.8 | 7.5 | GO:0080111 | DNA demethylation(GO:0080111) |
0.8 | 5.0 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.8 | 4.9 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.8 | 4.1 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.8 | 3.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.8 | 2.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.8 | 2.4 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 1.6 | GO:0042253 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.8 | 0.8 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.8 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.8 | 3.9 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.8 | 14.9 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.8 | 17.8 | GO:0003407 | neural retina development(GO:0003407) |
0.8 | 1.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.8 | 3.1 | GO:0032308 | positive regulation of prostaglandin secretion(GO:0032308) |
0.8 | 6.1 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.8 | 6.1 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.8 | 2.3 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.8 | 2.3 | GO:0060004 | reflex(GO:0060004) |
0.8 | 1.5 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
0.8 | 3.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.7 | 2.2 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.7 | 0.7 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
0.7 | 2.2 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.7 | 3.7 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.7 | 2.9 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.7 | 3.7 | GO:0060736 | prostate gland growth(GO:0060736) |
0.7 | 3.7 | GO:0080009 | mRNA methylation(GO:0080009) |
0.7 | 2.9 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.7 | 2.9 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.7 | 1.5 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.7 | 4.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.7 | 9.3 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.7 | 9.3 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.7 | 1.4 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.7 | 4.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.7 | 0.7 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.7 | 0.7 | GO:0061196 | fungiform papilla development(GO:0061196) |
0.7 | 2.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.7 | 0.7 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.7 | 6.2 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.7 | 14.5 | GO:0019228 | neuronal action potential(GO:0019228) |
0.7 | 1.4 | GO:0097694 | establishment of RNA localization to telomere(GO:0097694) |
0.7 | 0.7 | GO:2000969 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.7 | 6.8 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.7 | 2.7 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.7 | 4.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.7 | 6.1 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
0.7 | 3.4 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.7 | 2.0 | GO:0009212 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
0.7 | 0.7 | GO:0035766 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.7 | 4.0 | GO:0007207 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.7 | 4.0 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.7 | 0.7 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.7 | 5.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.7 | 13.9 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
0.7 | 2.0 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
0.7 | 2.0 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.7 | 9.9 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.7 | 2.0 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.7 | 5.2 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.7 | 2.6 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
0.6 | 1.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.6 | 0.6 | GO:0090494 | catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.6 | 1.9 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.6 | 2.6 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.6 | 0.6 | GO:0061439 | renal system vasculature morphogenesis(GO:0061438) kidney vasculature morphogenesis(GO:0061439) glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.6 | 1.9 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.6 | 1.3 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.6 | 3.1 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.6 | 3.1 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.6 | 0.6 | GO:0090135 | actin filament branching(GO:0090135) |
0.6 | 0.6 | GO:0061341 | non-canonical Wnt signaling pathway involved in heart development(GO:0061341) planar cell polarity pathway involved in heart morphogenesis(GO:0061346) |
0.6 | 4.8 | GO:0006983 | ER overload response(GO:0006983) |
0.6 | 4.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.6 | 1.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.6 | 11.4 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.6 | 1.8 | GO:0045297 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.6 | 3.6 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.6 | 1.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.6 | 2.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.6 | 2.3 | GO:1902308 | regulation of peptidyl-serine dephosphorylation(GO:1902308) |
0.6 | 4.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.6 | 0.6 | GO:0009080 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) |
0.6 | 1.7 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.6 | 4.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.6 | 1.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.6 | 0.6 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.5 | 2.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.5 | 1.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.5 | 1.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.5 | 2.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 5.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.5 | 5.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.5 | 1.6 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.5 | 0.5 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.5 | 1.1 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.5 | 1.0 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.5 | 0.5 | GO:2000449 | regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
0.5 | 1.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.5 | 1.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.5 | 13.6 | GO:0034605 | cellular response to heat(GO:0034605) |
0.5 | 1.5 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.5 | 1.0 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.5 | 1.0 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
0.5 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 2.9 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.5 | 1.9 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.5 | 0.5 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.5 | 0.9 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.5 | 7.1 | GO:0008347 | glial cell migration(GO:0008347) |
0.5 | 1.4 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.5 | 1.9 | GO:0001975 | response to amphetamine(GO:0001975) |
0.5 | 3.7 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.5 | 0.5 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.5 | 0.9 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.5 | 0.9 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.5 | 0.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.5 | 0.9 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.5 | 1.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.5 | 0.5 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.4 | 1.8 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.4 | 4.0 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.4 | 0.4 | GO:0060751 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.4 | 2.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 2.6 | GO:0015884 | folic acid transport(GO:0015884) |
0.4 | 0.9 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
0.4 | 4.3 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.4 | 1.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.4 | 3.4 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
0.4 | 0.8 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.4 | 0.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.4 | 3.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.4 | 4.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.4 | 1.7 | GO:2000399 | negative regulation of thymocyte aggregation(GO:2000399) |
0.4 | 1.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 0.4 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.4 | 6.2 | GO:0032292 | Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.4 | 1.2 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.4 | 0.8 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.4 | 6.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.4 | 0.8 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.4 | 0.8 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.4 | 2.4 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.4 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.4 | 3.1 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.4 | 0.8 | GO:2000850 | negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
0.4 | 1.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.4 | 0.4 | GO:1902667 | regulation of axon guidance(GO:1902667) |
0.4 | 1.2 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.4 | 2.3 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.4 | 1.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.4 | 0.8 | GO:0070268 | cornification(GO:0070268) |
0.4 | 18.9 | GO:0007411 | axon guidance(GO:0007411) |
0.4 | 2.6 | GO:0010667 | negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.4 | 2.2 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.4 | 1.5 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 0.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 0.4 | GO:0090237 | regulation of arachidonic acid secretion(GO:0090237) |
0.4 | 0.7 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.4 | 0.4 | GO:1901859 | negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.4 | 1.1 | GO:2000551 | regulation of T-helper 2 cell cytokine production(GO:2000551) |
0.4 | 1.1 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.3 | 1.7 | GO:1901341 | positive regulation of store-operated calcium channel activity(GO:1901341) |
0.3 | 0.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.3 | 0.7 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.3 | 0.7 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 0.6 | GO:0042640 | anagen(GO:0042640) |
0.3 | 2.9 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 2.8 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.3 | 0.6 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.3 | 0.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.3 | 1.2 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.3 | 0.9 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.3 | 0.9 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.3 | 0.3 | GO:0051795 | regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
0.3 | 0.9 | GO:0035747 | natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
0.3 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 0.3 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.3 | 1.7 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.3 | 0.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 6.6 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.3 | 1.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.3 | 0.3 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.3 | 1.1 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.3 | 1.1 | GO:0070472 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) |
0.3 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.3 | 0.5 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.3 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.3 | 1.5 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.3 | 0.8 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 6.3 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 0.3 | GO:1904833 | regulation of superoxide dismutase activity(GO:1901668) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
0.2 | 0.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.2 | 7.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 0.5 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.2 | 0.9 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.7 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.2 | 0.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 0.2 | GO:0086011 | membrane repolarization during action potential(GO:0086011) |
0.2 | 0.5 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 0.7 | GO:0036093 | germ cell proliferation(GO:0036093) |
0.2 | 2.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.2 | 0.9 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.2 | 0.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.2 | 0.7 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.2 | 1.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.2 | 0.4 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.2 | GO:0009217 | purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) |
0.2 | 0.9 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.2 | 0.2 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.2 | 0.4 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 2.9 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.2 | 0.2 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
0.2 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.4 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 0.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.2 | 0.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.2 | GO:0097485 | neuron projection guidance(GO:0097485) |
0.2 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 0.6 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.2 | 1.0 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.2 | 0.6 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.2 | 0.2 | GO:0072173 | metanephric tubule morphogenesis(GO:0072173) |
0.2 | 1.7 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.2 | 0.8 | GO:0033605 | positive regulation of catecholamine secretion(GO:0033605) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.7 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.2 | 3.0 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.7 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 0.5 | GO:0019249 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 1.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 3.0 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.2 | 0.3 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.2 | 0.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 0.7 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 1.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 0.5 | GO:1905097 | regulation of guanyl-nucleotide exchange factor activity(GO:1905097) |
0.2 | 0.8 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.2 | 1.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.2 | 0.3 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
0.2 | 0.5 | GO:0097384 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.2 | 0.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.9 | GO:0008616 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.1 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.1 | 1.6 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.1 | 0.3 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.1 | 0.1 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 0.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.1 | 0.8 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.1 | GO:0061055 | myotome development(GO:0061055) |
0.1 | 0.5 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.3 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.1 | 0.1 | GO:1903431 | positive regulation of cell maturation(GO:1903431) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.1 | 1.2 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.1 | 0.1 | GO:0010454 | negative regulation of cell fate commitment(GO:0010454) |
0.1 | 0.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 0.7 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.1 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.3 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.3 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
0.1 | 0.1 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) |
0.1 | 0.2 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.1 | 0.3 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 0.1 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 0.1 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
0.1 | 0.1 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.1 | 0.2 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.1 | 0.2 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.1 | 0.1 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.1 | 0.2 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.1 | 0.1 | GO:0038001 | paracrine signaling(GO:0038001) |
0.1 | 0.1 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.3 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 1.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.2 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.0 | 0.1 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.2 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.1 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.0 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.0 | 0.2 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.0 | 0.0 | GO:0032303 | regulation of icosanoid secretion(GO:0032303) |
0.0 | 0.0 | GO:0060926 | cardiac pacemaker cell differentiation(GO:0060920) cardiac pacemaker cell development(GO:0060926) |
0.0 | 0.0 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.0 | 0.0 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.0 | 0.1 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
17.9 | 53.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
9.7 | 96.9 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
8.2 | 49.3 | GO:0016012 | sarcoglycan complex(GO:0016012) |
7.7 | 53.8 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
7.6 | 22.9 | GO:0072534 | perineuronal net(GO:0072534) |
5.8 | 29.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
5.7 | 68.4 | GO:0043194 | axon initial segment(GO:0043194) |
5.7 | 90.8 | GO:0048786 | presynaptic active zone(GO:0048786) |
5.6 | 28.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
5.3 | 127.9 | GO:0044295 | axonal growth cone(GO:0044295) |
5.3 | 26.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
5.2 | 36.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
4.8 | 4.8 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
4.8 | 24.0 | GO:0097433 | dense body(GO:0097433) |
4.4 | 220.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
4.4 | 26.1 | GO:0032584 | growth cone membrane(GO:0032584) |
4.3 | 34.7 | GO:0042788 | polysomal ribosome(GO:0042788) |
4.3 | 17.3 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
4.2 | 41.7 | GO:0030673 | axolemma(GO:0030673) |
4.0 | 7.9 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
3.9 | 11.8 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
3.9 | 54.9 | GO:0043196 | varicosity(GO:0043196) |
3.6 | 43.7 | GO:0032426 | stereocilium tip(GO:0032426) |
3.4 | 30.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
3.2 | 9.5 | GO:0033010 | paranodal junction(GO:0033010) |
3.2 | 41.2 | GO:0031045 | dense core granule(GO:0031045) |
3.2 | 34.7 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
3.0 | 11.8 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
2.9 | 48.7 | GO:0005614 | interstitial matrix(GO:0005614) |
2.8 | 5.6 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
2.7 | 8.2 | GO:0048179 | activin receptor complex(GO:0048179) |
2.6 | 10.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
2.6 | 20.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
2.5 | 17.8 | GO:0071437 | invadopodium(GO:0071437) |
2.5 | 9.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
2.3 | 6.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
2.2 | 6.7 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.2 | 32.9 | GO:0031527 | filopodium membrane(GO:0031527) |
2.1 | 10.5 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
2.0 | 2.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
2.0 | 20.0 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
2.0 | 5.9 | GO:0097441 | basilar dendrite(GO:0097441) |
2.0 | 5.9 | GO:0032280 | symmetric synapse(GO:0032280) |
2.0 | 2.0 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
1.9 | 5.8 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
1.8 | 16.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.8 | 1.8 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
1.8 | 7.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.8 | 37.1 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
1.7 | 11.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.7 | 5.1 | GO:0000322 | storage vacuole(GO:0000322) |
1.7 | 3.3 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
1.6 | 11.4 | GO:0043083 | synaptic cleft(GO:0043083) |
1.6 | 6.5 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
1.6 | 92.7 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
1.6 | 25.2 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
1.6 | 4.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
1.5 | 7.7 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
1.5 | 13.6 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
1.5 | 6.0 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
1.5 | 33.1 | GO:0043198 | dendritic shaft(GO:0043198) |
1.5 | 6.0 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
1.5 | 6.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
1.5 | 8.8 | GO:0033270 | paranode region of axon(GO:0033270) |
1.5 | 16.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
1.4 | 130.8 | GO:0045211 | postsynaptic membrane(GO:0045211) |
1.4 | 8.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
1.3 | 10.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
1.2 | 194.7 | GO:0060076 | excitatory synapse(GO:0060076) |
1.2 | 16.9 | GO:0043205 | fibril(GO:0043205) |
1.2 | 3.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
1.1 | 3.4 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.1 | 19.1 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
1.1 | 6.4 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
1.1 | 4.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 11.3 | GO:0042555 | MCM complex(GO:0042555) |
1.0 | 3.8 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.9 | 11.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.9 | 11.4 | GO:0097546 | ciliary base(GO:0097546) |
0.9 | 4.4 | GO:0061617 | MICOS complex(GO:0061617) |
0.9 | 20.5 | GO:0032420 | stereocilium(GO:0032420) |
0.8 | 4.2 | GO:0071547 | piP-body(GO:0071547) |
0.8 | 5.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.8 | 2.4 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 46.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.8 | 5.4 | GO:0033263 | CORVET complex(GO:0033263) |
0.7 | 6.6 | GO:0036156 | inner dynein arm(GO:0036156) |
0.7 | 4.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.7 | 2.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.7 | 52.8 | GO:0030426 | growth cone(GO:0030426) |
0.7 | 4.1 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.7 | 2.0 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.7 | 4.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.7 | 8.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.6 | 14.9 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.6 | 29.8 | GO:0043195 | terminal bouton(GO:0043195) |
0.6 | 9.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.6 | 13.0 | GO:0098794 | postsynapse(GO:0098794) |
0.6 | 4.1 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 0.6 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.5 | 1.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 2.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.5 | 4.0 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.5 | 6.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.5 | 4.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.5 | 4.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.5 | 5.6 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 59.3 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.4 | 1.2 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 1.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.4 | 0.8 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.4 | 1.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.4 | 1.1 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.4 | 0.4 | GO:0035838 | growing cell tip(GO:0035838) |
0.4 | 0.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.4 | 2.8 | GO:0044447 | axoneme part(GO:0044447) |
0.4 | 1.1 | GO:0000802 | transverse filament(GO:0000802) |
0.4 | 8.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.3 | 5.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.3 | 1.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.3 | 1.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.6 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 5.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 1.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 1.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.3 | 0.8 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.3 | 0.8 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 4.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 12.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 1.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 0.5 | GO:1990923 | PET complex(GO:1990923) |
0.2 | 0.9 | GO:0070876 | SOSS complex(GO:0070876) |
0.2 | 5.7 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 1.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.2 | 0.4 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.2 | 1.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 1.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.8 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 11.6 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.2 | 0.9 | GO:0000796 | condensin complex(GO:0000796) |
0.2 | 0.5 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 0.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.1 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 21.5 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 0.9 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 1.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 3.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.1 | 0.2 | GO:0042583 | chromaffin granule(GO:0042583) |
0.1 | 0.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 2.1 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 3.2 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.5 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.2 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0035061 | interchromatin granule(GO:0035061) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 0.2 | GO:0005687 | U4 snRNP(GO:0005687) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
37.1 | 111.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
24.4 | 73.3 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
13.8 | 41.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
13.6 | 68.2 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
13.1 | 52.5 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
12.5 | 37.5 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
9.6 | 38.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
8.3 | 41.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
8.3 | 41.6 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
8.2 | 24.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
8.1 | 24.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
7.7 | 23.1 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
7.2 | 21.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
6.8 | 27.1 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
6.7 | 46.7 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
6.4 | 25.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
6.4 | 19.1 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
6.2 | 12.5 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
5.9 | 17.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
5.8 | 17.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
5.8 | 17.4 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
5.7 | 51.5 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
5.3 | 16.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
5.2 | 10.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
4.8 | 28.7 | GO:0004385 | guanylate kinase activity(GO:0004385) |
4.7 | 28.3 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
4.5 | 27.1 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
4.5 | 40.1 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
4.1 | 37.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
4.0 | 16.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
3.8 | 3.8 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
3.8 | 22.5 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
3.7 | 22.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
3.6 | 79.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
3.6 | 10.8 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
3.5 | 31.7 | GO:0038191 | neuropilin binding(GO:0038191) |
3.5 | 17.5 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
3.5 | 20.9 | GO:0048495 | Roundabout binding(GO:0048495) |
3.5 | 10.4 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
3.4 | 10.1 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
3.3 | 39.7 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
3.3 | 3.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
3.3 | 13.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
3.3 | 9.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
3.2 | 6.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
3.1 | 9.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
3.1 | 9.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
3.1 | 12.2 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
3.1 | 12.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
2.9 | 20.4 | GO:0043495 | protein anchor(GO:0043495) |
2.9 | 11.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
2.8 | 14.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
2.7 | 8.1 | GO:0016015 | morphogen activity(GO:0016015) |
2.7 | 8.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
2.6 | 31.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
2.6 | 5.2 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
2.5 | 17.8 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
2.5 | 7.5 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.5 | 32.0 | GO:0050811 | GABA receptor binding(GO:0050811) |
2.4 | 14.3 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
2.4 | 9.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
2.4 | 47.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
2.4 | 35.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
2.3 | 16.3 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
2.3 | 7.0 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.3 | 25.4 | GO:0017065 | single-strand selective uracil DNA N-glycosylase activity(GO:0017065) nicotinamide riboside hydrolase activity(GO:0070635) nicotinic acid riboside hydrolase activity(GO:0070636) deoxyribonucleoside 5'-monophosphate N-glycosidase activity(GO:0070694) |
2.3 | 46.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
2.3 | 13.5 | GO:0032027 | myosin light chain binding(GO:0032027) |
2.2 | 6.6 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
2.2 | 8.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
2.2 | 8.7 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
2.2 | 8.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
2.2 | 4.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
2.2 | 4.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
2.2 | 8.7 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
2.1 | 49.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
2.1 | 23.5 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
2.1 | 8.5 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
2.1 | 6.3 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
2.0 | 10.2 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
2.0 | 6.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
2.0 | 8.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
2.0 | 8.1 | GO:0097001 | ceramide binding(GO:0097001) |
2.0 | 6.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.0 | 6.0 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
2.0 | 12.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
2.0 | 10.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
2.0 | 6.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
2.0 | 10.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.9 | 9.7 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
1.9 | 11.4 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
1.8 | 16.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
1.8 | 7.3 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.8 | 27.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
1.8 | 3.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
1.8 | 19.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
1.7 | 8.7 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
1.7 | 34.8 | GO:0003785 | actin monomer binding(GO:0003785) |
1.7 | 7.0 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.7 | 6.9 | GO:0051434 | BH3 domain binding(GO:0051434) |
1.7 | 3.4 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
1.7 | 8.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.7 | 36.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
1.6 | 4.8 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.6 | 4.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.6 | 4.7 | GO:0035939 | microsatellite binding(GO:0035939) |
1.5 | 20.9 | GO:0045295 | gamma-catenin binding(GO:0045295) |
1.5 | 3.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
1.5 | 5.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
1.4 | 8.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.4 | 5.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.4 | 6.9 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
1.3 | 4.0 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
1.3 | 17.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
1.3 | 33.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
1.3 | 13.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
1.3 | 3.9 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.3 | 1.3 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.3 | 6.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.3 | 5.2 | GO:0034056 | estrogen response element binding(GO:0034056) |
1.3 | 3.9 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.3 | 17.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
1.2 | 6.2 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
1.2 | 9.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
1.2 | 1.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.2 | 4.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.2 | 21.6 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
1.2 | 4.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.1 | 2.3 | GO:0004359 | glutaminase activity(GO:0004359) |
1.1 | 6.9 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
1.1 | 3.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
1.1 | 4.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
1.1 | 10.0 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
1.1 | 15.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) GABA receptor activity(GO:0016917) |
1.1 | 3.3 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
1.1 | 3.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
1.1 | 3.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
1.1 | 4.3 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
1.1 | 11.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
1.1 | 13.8 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 2.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
1.0 | 2.0 | GO:0097016 | L27 domain binding(GO:0097016) |
1.0 | 27.1 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.0 | 27.9 | GO:0005272 | sodium channel activity(GO:0005272) |
1.0 | 4.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.0 | 10.0 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
1.0 | 5.9 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
1.0 | 6.7 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.9 | 2.8 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.9 | 3.7 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 2.7 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.9 | 2.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.9 | 30.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.9 | 17.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.9 | 10.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.9 | 6.0 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.9 | 1.7 | GO:0051425 | PTB domain binding(GO:0051425) |
0.8 | 2.5 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.8 | 1.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.8 | 17.4 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.8 | 1.6 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
0.8 | 0.8 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.8 | 2.4 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.8 | 4.8 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.8 | 3.9 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.8 | 16.3 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.8 | 5.4 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.8 | 2.3 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.7 | 8.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.7 | 2.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.7 | 1.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.7 | 29.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.7 | 6.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.7 | 7.1 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.7 | 4.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.7 | 9.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.7 | 60.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.7 | 0.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.7 | 2.8 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 2.8 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 2.8 | GO:0034584 | piRNA binding(GO:0034584) |
0.7 | 2.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.7 | 4.0 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.7 | 2.7 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.7 | 9.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.7 | 2.0 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.7 | 2.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.7 | 23.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.7 | 19.0 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.6 | 2.6 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.6 | 1.9 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.6 | 1.9 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 1.9 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.6 | 3.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.6 | 0.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.6 | 1.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.6 | 1.8 | GO:0032190 | acrosin binding(GO:0032190) |
0.6 | 1.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.6 | 0.6 | GO:0004952 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) dopamine neurotransmitter receptor activity(GO:0004952) |
0.6 | 6.7 | GO:0030955 | potassium ion binding(GO:0030955) |
0.6 | 7.8 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.6 | 1.7 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.6 | 11.6 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 15.9 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.5 | 1.1 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.5 | 1.6 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.5 | 3.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.5 | 10.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 9.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 3.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.5 | 2.6 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.5 | 3.0 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.5 | 2.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.5 | 2.5 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.5 | 2.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.5 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 4.4 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.5 | 2.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.5 | 5.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.5 | 2.8 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.5 | 5.6 | GO:0031005 | filamin binding(GO:0031005) |
0.5 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.5 | 1.4 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.5 | 1.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 1.8 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.4 | 2.2 | GO:0045545 | syndecan binding(GO:0045545) |
0.4 | 2.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.4 | 12.6 | GO:0070888 | E-box binding(GO:0070888) |
0.4 | 8.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.4 | 4.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.4 | 1.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.4 | 0.4 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.4 | 1.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.4 | 1.6 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.4 | 1.2 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.4 | 0.4 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.4 | 1.2 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 4.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.4 | 2.7 | GO:0030553 | cGMP binding(GO:0030553) |
0.4 | 0.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.4 | 1.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.4 | 2.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.3 | 5.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 3.7 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 1.0 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.3 | 2.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.3 | 0.3 | GO:0055100 | adiponectin binding(GO:0055100) |
0.3 | 17.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.3 | 1.2 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.3 | 3.1 | GO:0022821 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) potassium ion antiporter activity(GO:0022821) |
0.3 | 4.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.3 | 3.4 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.3 | 1.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 0.9 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.3 | 0.6 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.3 | 2.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 1.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.3 | 0.8 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.2 | 1.2 | GO:0018812 | 3-hydroxyacyl-CoA dehydratase activity(GO:0018812) |
0.2 | 5.9 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.2 | 5.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.2 | 1.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 3.0 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.2 | 5.0 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.2 | 0.9 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.2 | 0.6 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.2 | 1.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 3.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.9 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.6 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.7 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.2 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
0.2 | 0.5 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.2 | 0.5 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.2 | 0.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.2 | 5.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.2 | 1.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.2 | 0.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.3 | GO:0022835 | transmitter-gated ion channel activity(GO:0022824) transmitter-gated channel activity(GO:0022835) |
0.2 | 2.7 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 5.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 1.1 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.1 | 0.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.4 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.1 | 0.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 0.9 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
0.1 | 1.8 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.1 | 0.3 | GO:0035870 | dITP diphosphatase activity(GO:0035870) |
0.1 | 1.5 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 1.9 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.1 | 1.2 | GO:0070990 | snRNP binding(GO:0070990) |
0.1 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 0.9 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.1 | 0.8 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 0.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.1 | 0.1 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.1 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.2 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.1 | 1.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 1.3 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.1 | 1.2 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.1 | 1.4 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.0 | 0.4 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.1 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.2 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.0 | 2.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 5.2 | GO:0005549 | odorant binding(GO:0005549) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.9 | 157.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
3.2 | 9.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
3.1 | 3.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
2.2 | 41.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
1.9 | 5.8 | ST G ALPHA I PATHWAY | G alpha i Pathway |
1.6 | 3.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.4 | 37.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
1.3 | 14.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.3 | 15.3 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
1.0 | 27.2 | ST ADRENERGIC | Adrenergic Pathway |
1.0 | 13.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.9 | 2.8 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.9 | 24.9 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.9 | 24.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.9 | 2.6 | PID INSULIN PATHWAY | Insulin Pathway |
0.8 | 0.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.8 | 6.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.8 | 6.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.7 | 8.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 2.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.7 | 0.7 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.6 | 1.9 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.6 | 2.5 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 5.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 9.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.5 | 16.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.5 | 13.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 4.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.4 | 1.5 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 52.7 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.4 | 7.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 10.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.4 | 1.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 2.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.3 | 0.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.3 | 9.2 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 4.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.3 | 46.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.3 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.2 | 0.4 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.2 | 9.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 0.4 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 19.4 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.1 | 0.5 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 36.7 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
4.6 | 118.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
3.5 | 58.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
3.4 | 104.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
3.1 | 34.4 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
3.1 | 21.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
3.1 | 37.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
3.0 | 54.2 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
2.8 | 5.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
2.6 | 36.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
2.6 | 21.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
2.6 | 39.4 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
2.6 | 17.9 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
2.5 | 32.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
2.5 | 27.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
2.5 | 54.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
2.4 | 28.6 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
2.3 | 2.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.3 | 9.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
2.0 | 24.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
2.0 | 38.3 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
2.0 | 86.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
2.0 | 8.0 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.0 | 31.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
1.7 | 5.2 | REACTOME SIGNALLING BY NGF | Genes involved in Signalling by NGF |
1.7 | 5.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
1.6 | 6.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
1.6 | 25.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
1.6 | 3.1 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.5 | 15.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
1.5 | 13.3 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
1.4 | 53.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
1.3 | 21.0 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
1.3 | 24.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
1.3 | 10.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.2 | 21.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.1 | 13.4 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
1.1 | 1.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.1 | 9.6 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
1.0 | 13.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.9 | 6.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.9 | 9.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.9 | 0.9 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.9 | 9.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.9 | 8.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.8 | 2.5 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.8 | 3.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.7 | 21.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.7 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.7 | 4.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.7 | 7.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 2.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.6 | 7.9 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.6 | 3.0 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.6 | 18.7 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.6 | 6.7 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.5 | 1.1 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.5 | 5.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.5 | 10.6 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.5 | 3.0 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.5 | 13.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.4 | 2.7 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 15.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 0.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.4 | 5.7 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.4 | 3.4 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.4 | 13.4 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
0.4 | 0.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.3 | 2.6 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.3 | 25.4 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.3 | 5.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.3 | 0.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.3 | 4.4 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 0.6 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.3 | 1.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 1.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.2 | 3.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.2 | 2.9 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 1.4 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 2.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 3.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 1.2 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.2 | 4.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 0.6 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 2.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.2 | 0.2 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.2 | 2.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 0.8 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.5 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
0.1 | 4.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 2.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 10.9 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.1 | 1.3 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 0.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.5 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.0 | 0.0 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.6 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |